Isoginkgetin derivative IP2 enhances the adaptive immune response against tumor antigens.
Darrigrand R, Pierson A, Rouillon M, Renko D, Boulpicante M, Bouyssié D, Mouton-Barbosa E, Marcoux J, Garcia C, Ghosh M, Alami M, Apcher S.
Darrigrand R, et al. Among authors: apcher s.
Commun Biol. 2021 Mar 1;4(1):269. doi: 10.1038/s42003-021-01801-2.
Commun Biol. 2021.
PMID: 33649389
Free PMC article.